The WHO said it will assess the need for a Global Medical Products Alert on Coldrif syrup once it receives official confirmation from the Indian authorities.
Related Posts
Ranchi Overhauls Hospital Revenue Utilization
Post Views: 26 Jharkhand has implemented a new policy allowing…
Cough syrup deaths: SC rejects PIL seeking CBI probe, nationwide drug safety review
Post Views: 16 A bench comprising Chief Justice B R…
India’s healthcare future hinges on data: Experts call for curation, sharing, and AI adoption
Post Views: 14 At a high-powered panel on future technologies,…